Mondego Bio Launches with Series A Funding for AI-Driven Cancer Therapies
Expert Systems Inc. has announced the launch of Mondego Bio, an emerging immuno-oncology company, with Series A funding. Announced in a press release, the new venture is supported by Biovance Capital, Torrey Pines Investment, and OrbiMed.
Mondego Bio is focused on developing a portfolio of first- and best-in-class PTPN2 inhibitors aimed at transforming cancer immunotherapy. These drug candidates have been designed and optimized using Expert Systems' AI/ML-driven molecular design and predictive pharmacology platform, significantly accelerating the path from concept to clinical readiness.
Expert Systems will continue to provide strategic, scientific, and technological support as Mondego Bio advances its pipeline into first-in-human studies. This collaboration underscores Expert Systems' capability to create and scale high-value biotech ventures, reducing early-stage innovation risks for investors and partners.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designMore from Funding
Nov 20 hackajob raises $10 million to expand Archer, its AI recruiting agent Nov 20 Protesters rally against Anthropic in New York and San Francisco on its stock market debut Nov 19 Anthropic's IPO could channel about $156 billion to charity, TechCrunch estimates Nov 19 Sierra reportedly in talks to raise at a $30 billion valuation Nov 19 Everful raises $48.5 million to build AI infrastructure for global commerceAI Funding Brief
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Atlas Bio raises $12.5 million for virtual drug trials
Isomorphic Labs and MSD team up to design cancer drugs with AI
Mondrio Raises $3.75 Million for AI B2B Pricing Agents
Switchpoint Bio raises $5.3 million for AI epigenomics platform
ALLOX Raises $10.5 Million for AI Drug Discovery Platform
Daily AI Brief: the AI news that matters, in your inbox.